Mounjaro is a twin GIP and GLP-one receptor agonist, whilst Wegovy acts exclusively within the GLP-1 receptor. Mounjaro could possibly have a stronger impact on human body excess weight, but isn't solely approved for weight loss. Like Wegovy, Mounjaro is injected once every week. It is additionally successful in adolescents https://felixxazvk.weblogco.com/39471672/the-5-second-trick-for-what-kind-of-drug-is-ecstasy